ASTRAZEN
Invest with MTF
Invest Now
Invest in AstraZeneca Pharma India with 3.24X leverage
Performance
- Low
- ₹8,647
- High
- ₹8,777
- 52 Week Low
- ₹6,620
- 52 Week High
- ₹10,691
- Open Price₹8,698
- Previous Close₹8,630
- Volume6,215
- 50 DMA₹8,692.02
- 100 DMA₹8,803.33
- 200 DMA₹8,636.45
Investment Returns
- Over 1 Month + 1.26%
- Over 3 Month -8.84%
- Over 6 Month -2.06%
- Over 1 Year + 17.54%
Smart Investing Starts Here Start SIP with AstraZeneca Pharma India for Steady Growth!
AstraZeneca Pharma India Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 109.3
- PEG Ratio
- 0.8
- Market Cap Cr
- 21,775
- P/B Ratio
- 27.3
- Average True Range
- 200.12
- EPS
- 92.47
- Dividend Yield
- 0.4
- MACD Signal
- -116.84
- RSI
- 58.34
- MFI
- 40.27
AstraZeneca Pharma India Financials
AstraZeneca Pharma India Technicals
EMA & SMA
Current Price
₹8,710.00
+
80.5
(0.93%)
- Bearish Moving Average 5
- Bullish Moving Average 11
- 20 Day
- ₹8,513.75
- 50 Day
- ₹8,692.02
- 100 Day
- ₹8,803.33
- 200 Day
- ₹8,636.45
Resistance and Support
8711.17
- R3 8,906.33
- R2 8,841.67
- R1 8,775.83
- S1 8,645.33
- S2 8,580.67
- S3 8,514.83
AstraZeneca Pharma India Corporate Actions - Bonus, Splits, Dividends
AstraZeneca Pharma India F&O
About AstraZeneca Pharma India
- NSE Symbol
- ASTRAZEN
- BSE Symbol
- 506820
- Managing Director
- Mr. Praveen Rao Akkinepally
- ISIN
- INE203A01020
Similar Stocks to AstraZeneca Pharma India
AstraZeneca Pharma India FAQs
AstraZeneca Pharma India share price is ₹8,710 As on 03 February, 2026 | 20:18
The Market Cap of AstraZeneca Pharma India is ₹21775 Cr As on 03 February, 2026 | 20:18
The P/E ratio of AstraZeneca Pharma India is 109.3 As on 03 February, 2026 | 20:18
The PB ratio of AstraZeneca Pharma India is 27.3 As on 03 February, 2026 | 20:18
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.